Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Drug-RNA footprinting.

M P McPike1, J Goodisman, J C Dabrowiak

  • 1Department of Chemistry, Center for Science and Technology, Syracuse University, Syracuse, New York 13244, USA.

Methods in Enzymology
|August 10, 2001
PubMed
Summary

Paromomycin binding to HIV-1 packaging RNA alters its structure, revealing potential therapeutic targets. This research identifies key binding sites and drug-induced changes, paving the way for new anti-HIV agents.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Smoluchowski Equations for Agglomeration in Conditions of Variable Temperature and Pressure and a New Scaling of Rate Constants: Application to Nozzle-Beam Expansion.

The journal of physical chemistry. A·2015
Same author

Scaling and the Smoluchowski equations.

The Journal of chemical physics·2006
Same author

Application of scaling and kinetic equations to helium cluster size distributions: Homogeneous nucleation of a nearly ideal gas.

The Journal of chemical physics·2006
Same author

Characterization of hairpin-duplex interconversion of DNA using polyacrylamide gel electrophoresis.

Biophysical chemistry·2001
Same author

Binding of human immunodeficiency virus type 1 nucleocapsid protein to psi-RNA-SL3.

Biophysical chemistry·2000
Same author

Monomer-dimer equilibrium constants of RNA in the dimer initiation site of human immunodeficiency virus type 1.

Biochemistry·1999

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Virology

Background:

  • The packaging region of Human Immunodeficiency Virus type 1 (HIV-1) RNA is crucial for viral replication.
  • Understanding drug interactions with viral RNA is essential for developing antiviral therapies.

Purpose of the Study:

  • To investigate the binding sites and structural effects of paromomycin on the HIV-1 packaging RNA (176-mer).
  • To assess the potential of paromomycin analogs as anti-HIV agents.

Main Methods:

  • Utilized RNase I and RNase T1 footprinting to map paromomycin binding.
  • Quantified autoradiographic data to analyze drug concentration-dependent cleavage patterns.
  • Identified binding sites and drug-induced structural alterations.

Main Results:

  • Paromomycin primarily binds to the main stem and SL1 stem of the HIV-1 RNA.
  • Drug binding induces structural changes in linker regions between stem-loops.
  • Noncontiguous RNA sequences may participate in paromomycin binding.

Conclusions:

  • Paromomycin binding significantly alters the structure of the HIV-1 packaging region.
  • These structural changes suggest potential for novel therapeutic strategies.
  • Paromomycin analogs could represent a new class of agents for treating Acquired Immunodeficiency Syndrome (AIDS).

Related Experiment Videos